Biofrontera Balance Sheet Health
Financial Health criteria checks 4/6
Biofrontera has a total shareholder equity of €17.9M and total debt of €39.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are €24.2M and €6.3M respectively.
Key information
0.2%
Debt to equity ratio
€39.00k
Debt
Interest coverage ratio | n/a |
Cash | €2.21m |
Equity | €17.86m |
Total liabilities | €6.32m |
Total assets | €24.18m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B8FK's short term assets (€12.8M) exceed its short term liabilities (€5.9M).
Long Term Liabilities: B8FK's short term assets (€12.8M) exceed its long term liabilities (€466.0K).
Debt to Equity History and Analysis
Debt Level: B8FK has more cash than its total debt.
Reducing Debt: B8FK's debt to equity ratio has reduced from 77.4% to 0.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: B8FK has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: B8FK has less than a year of cash runway if free cash flow continues to grow at historical rates of 29.3% each year.